202 related articles for article (PubMed ID: 26965855)
21. Synthesis and antitumor activity of novel 2-amino-4-(3,5,5-trimethyl-2-pyrazolino)-1,3,5-triazine derivatives.
Brzozowski Z; Saczewski F
Eur J Med Chem; 2002 Sep; 37(9):709-20. PubMed ID: 12350288
[TBL] [Abstract][Full Text] [Related]
22. Synthesis and SAR of 4-(3-hydroxyphenylamino)pyrrolo[2,1-f][1,2,4]triazine based VEGFR-2 kinase inhibitors.
Borzilleri RM; Cai ZW; Ellis C; Fargnoli J; Fura A; Gerhardt T; Goyal B; Hunt JT; Mortillo S; Qian L; Tokarski J; Vyas V; Wautlet B; Zheng X; Bhide RS
Bioorg Med Chem Lett; 2005 Mar; 15(5):1429-33. PubMed ID: 15713401
[TBL] [Abstract][Full Text] [Related]
23. Synthesis of some new thioethers of 1,2,4-triazine-3-hydrazones and assays for their anticancer and anti human immune virus activities.
Abdel-Rahman RM; Seada M; Fawzy M; el-Baz I
Farmaco; 1993 Mar; 48(3):397-406. PubMed ID: 8323671
[TBL] [Abstract][Full Text] [Related]
24. Synthesis and antitumor activities of a series of novel quinoxalinhydrazides.
Grande F; Aiello F; Grazia OD; Brizzi A; Garofalo A; Neamati N
Bioorg Med Chem; 2007 Jan; 15(1):288-94. PubMed ID: 17085054
[TBL] [Abstract][Full Text] [Related]
25. [Studies on as-triazine derivatives. XVIII. Synthesis of 5,6-diaryl-1,2,4-triazine derivatives as blood platelet aggregation inhibitors].
Konno S; Kokubo T; Amano M; Yoshida N; Sagi M; Yamanaka H
Yakugaku Zasshi; 1992 Oct; 112(10):729-41. PubMed ID: 1469603
[TBL] [Abstract][Full Text] [Related]
26. Synthesis of heterobicyclic nitrogen systems bearing the 1,2,4-triazine moiety as anti-HIV and anticancer drugs: Part I.
Abdel-Rahman RM; Morsy JM; Hanafy F; Amene HA
Pharmazie; 1999 May; 54(5):347-51. PubMed ID: 10368828
[TBL] [Abstract][Full Text] [Related]
27. Biguanide-Based Synthesis of 1,3,5-Triazine Derivatives with Anticancer Activity and 1,3,5-Triazine Incorporated Calcium Citrate Nanoparticles.
Chalermnon M; Cherdchom S; Sereemaspun A; Rojanathanes R; Khotavivattana T
Molecules; 2021 Feb; 26(4):. PubMed ID: 33672071
[TBL] [Abstract][Full Text] [Related]
28. Identification of antitumour activity of novel derivatives of 8-aryl-2,6,7,8-tetrahydroimidazo[2,1-c][1,2,4]triazine-3,4-dione and 8-aryl-4-imino-2,3,7,8-tetrahydroimidazo[2,1-c][1,2,4]triazin-3(6H)-one.
Sztanke K; Pasternak K; Rzymowska J; Sztanke M; Kandefer-Szerszeń M; Dybała I; Kozioł AE
Bioorg Med Chem; 2007 Apr; 15(8):2837-49. PubMed ID: 17331732
[TBL] [Abstract][Full Text] [Related]
29. Selective synthesis and reactions of 6-substituted-2-beta-galactosyl-1,2,4-triazines of potential anticancer activity.
Mansour AK; Eid MM; Khalil NS
Nucleosides Nucleotides Nucleic Acids; 2003; 22(1):21-44. PubMed ID: 12708799
[TBL] [Abstract][Full Text] [Related]
30. Cyclic nucleotide phosphodiesterase type 4 inhibitors: evaluation of pyrazolo[1,5-a]-1,3,5-triazine ring system as an adenine bioisostere.
Raboisson P; Schultz D; Muller C; Reimund JM; Pinna G; Mathieu R; Bernard P; Do QT; Desjarlais RL; Justiano H; Lugnier C; Bourguignon JJ
Eur J Med Chem; 2008 Apr; 43(4):816-29. PubMed ID: 17640774
[TBL] [Abstract][Full Text] [Related]
31. Synthesis, crystal structure and anticancer activity of novel derivatives of ethyl 1-(4-oxo-8-aryl-4,6,7,8-tetrahydroimidazo[2,1-c][1,2,4]triazin-3-yl)formate.
Sztanke K; Rzymowska J; Niemczyk M; Dybała I; Kozioł AE
Eur J Med Chem; 2006 Apr; 41(4):539-47. PubMed ID: 16545495
[TBL] [Abstract][Full Text] [Related]
32. Synthesis and cytotoxic activity of trisubstituted-1,3,5-triazines.
Arya K; Dandia A
Bioorg Med Chem Lett; 2007 Jun; 17(12):3298-304. PubMed ID: 17449247
[TBL] [Abstract][Full Text] [Related]
33. 1, 2, 4-Triazine N-oxide derivatives: studies as potential hypoxic cytotoxins. Part II.
Cerecetto H; González M; Onetto S; Saenz P; Ezpeleta O; De Ceráin AL; Monge A
Arch Pharm (Weinheim); 2004 May; 337(5):247-58. PubMed ID: 15095418
[TBL] [Abstract][Full Text] [Related]
34. A novel microtubule destabilizing entity from orthogonal synthesis of triazine library and zebrafish embryo screening.
Moon HS; Jacobson EM; Khersonsky SM; Luzung MR; Walsh DP; Xiong W; Lee JW; Parikh PB; Lam JC; Kang TW; Rosania GR; Schier AF; Chang YT
J Am Chem Soc; 2002 Oct; 124(39):11608-9. PubMed ID: 12296721
[TBL] [Abstract][Full Text] [Related]
35. Irreversible enzyme inhibitors. 197. Water-soluble reversible inhibitors of dihydrofolate reductase with potent antitumor activity derived from 4, 6-diamino-1,2-dihydro-2,2-dimethyl-1-phenyl-s-triazine.
Baker BR; Ashton WT
J Med Chem; 1973 Mar; 16(3):209-14. PubMed ID: 4733101
[No Abstract] [Full Text] [Related]
36.
Dubey P; Pathak DP; Ali F; Chauhan G; Kalaiselvan V
Curr Drug Discov Technol; 2024; 21(2):e170723218813. PubMed ID: 37461340
[TBL] [Abstract][Full Text] [Related]
37. Ultrasound promoted green synthesis, anticancer evaluation, and molecular docking studies of hydrazines: a pilot trial.
Ali A; Ali A; Tahir A; Bakht MA; Ahsan MJ
J Enzyme Inhib Med Chem; 2022 Dec; 37(1):135-144. PubMed ID: 34894970
[TBL] [Abstract][Full Text] [Related]
38. Synthesis and anticancer evaluation of some new hydrazone derivatives of 2,6-dimethylimidazo[2,1-b][1,3,4]thiadiazole-5-carbohydrazide.
Terzioglu N; Gürsoy A
Eur J Med Chem; 2003; 38(7-8):781-6. PubMed ID: 12932910
[TBL] [Abstract][Full Text] [Related]
39. [Antineoplastics 17. Analysis of mono- and disubstituted 2,4-dichloro-5-diethylamino-1,3,5-triazines].
Kreutzberger A; Langner P; Stratmann J
Arch Pharm (Weinheim); 1991 Mar; 324(3):173-6. PubMed ID: 1859252
[TBL] [Abstract][Full Text] [Related]
40. Synthesis and aldose reductase inhibitory activity of triazine derivatives possessing acetic acid group.
Mavel S; Coudert P; Albuisson E; Duroux E; Bastide P; Couquelet J; Tronche P; Rubat C
Chem Pharm Bull (Tokyo); 1992 Jun; 40(6):1411-4. PubMed ID: 1394661
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
